Clinical trial
A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the…
NCT00135447 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00135447 |
|---|---|
| Title | A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen |
| Official title | A Phase IV, Multicenter, Cross-sectional Study to Evaluate the I50L Substitution Among Subjects Experiencing Virologic Failure on a HAART Regimen Containing Atazanavir (ATV) |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Enrollment | 5,000 |
| Start date | Sep 1, 2004 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Aug 26, 2005 |
| Last update posted | Apr 14, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: